In recent months there has been a sharp rise in the number of illegal medicines marketed as GLP-1 receptor agonists such as semaglutide, liraglutide and tirzepatide for weight loss and diabetes
Retatrutide, research peptides and illegal sales in the UK Strict caution must be taken against doses seen on social media, in forums or from unregulated research peptide sellers
Concerns about bone loss with GLP-1s come up often, yet the evidence consistently shows either preservation or slight gains in bone density
Is it bad to take a GLP-1 forever
1013 Assessing HIV treatment related worries and stigma: Psychometric properties of a novel, brief patient-reported outcome measure Irina Kolobova 1 , Tamra Keeney 2 , Christina Donatti 3 , Amara Orji 2 , Lauren Henning 2 , Dominy Browning 3 , Mark Kosinski 2 1 ViiV Healthcare, Durham, North Carolina, USA, 2 IQVIA Quality Metric, Inc., Providence, Rhode Island, USA, 3 ViiV Healthcare, London, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1013 Aims Many people with HIV (PWH) experience heightened emotional burden and challenges related to daily oral medication regimens, which impact well-being and treatment adherence
